nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0423	0.207	CbGbCtD
Morphine—CYP3A4—Cytarabine—lymphatic system cancer	0.0368	0.18	CbGbCtD
Morphine—CYP3A4—Teniposide—lymphatic system cancer	0.0363	0.177	CbGbCtD
Morphine—ABCB1—Vincristine—lymphatic system cancer	0.0291	0.142	CbGbCtD
Morphine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0254	0.124	CbGbCtD
Morphine—ABCB1—Methotrexate—lymphatic system cancer	0.0176	0.0861	CbGbCtD
Morphine—CYP3A4—Vincristine—lymphatic system cancer	0.0175	0.0852	CbGbCtD
Morphine—Erythema—Carmustine—lymphatic system cancer	0.00113	0.00142	CcSEcCtD
Morphine—Malnutrition—Carmustine—lymphatic system cancer	0.00113	0.00142	CcSEcCtD
Morphine—Cough—Bleomycin—lymphatic system cancer	0.00113	0.00142	CcSEcCtD
Morphine—Angiopathy—Vincristine—lymphatic system cancer	0.00113	0.00142	CcSEcCtD
Morphine—Diarrhoea—Teniposide—lymphatic system cancer	0.00112	0.00141	CcSEcCtD
Morphine—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00112	0.00141	CcSEcCtD
Morphine—Chest pain—Bleomycin—lymphatic system cancer	0.0011	0.00139	CcSEcCtD
Morphine—Coma—Methotrexate—lymphatic system cancer	0.0011	0.00138	CcSEcCtD
Morphine—Back pain—Carmustine—lymphatic system cancer	0.00109	0.00138	CcSEcCtD
Morphine—Discomfort—Bleomycin—lymphatic system cancer	0.00109	0.00137	CcSEcCtD
Morphine—Mental disorder—Vincristine—lymphatic system cancer	0.00109	0.00137	CcSEcCtD
Morphine—Chills—Mitoxantrone—lymphatic system cancer	0.00108	0.00136	CcSEcCtD
Morphine—Bladder pain—Methotrexate—lymphatic system cancer	0.00108	0.00136	CcSEcCtD
Morphine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00107	0.00135	CcSEcCtD
Morphine—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00107	0.00134	CcSEcCtD
Morphine—Confusional state—Bleomycin—lymphatic system cancer	0.00107	0.00134	CcSEcCtD
Morphine—Vision blurred—Carmustine—lymphatic system cancer	0.00107	0.00134	CcSEcCtD
Morphine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00106	0.00134	CcSEcCtD
Morphine—Tremor—Carmustine—lymphatic system cancer	0.00106	0.00133	CcSEcCtD
Morphine—Oedema—Bleomycin—lymphatic system cancer	0.00106	0.00133	CcSEcCtD
Morphine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00106	0.00133	CcSEcCtD
Morphine—Erythema—Mitoxantrone—lymphatic system cancer	0.00105	0.00132	CcSEcCtD
Morphine—Infection—Bleomycin—lymphatic system cancer	0.00105	0.00132	CcSEcCtD
Morphine—Anaemia—Carmustine—lymphatic system cancer	0.00105	0.00131	CcSEcCtD
Morphine—Back pain—Vincristine—lymphatic system cancer	0.00104	0.00131	CcSEcCtD
Morphine—Vomiting—Teniposide—lymphatic system cancer	0.00104	0.00131	CcSEcCtD
Morphine—Sepsis—Methotrexate—lymphatic system cancer	0.00104	0.00131	CcSEcCtD
Morphine—Agitation—Carmustine—lymphatic system cancer	0.00104	0.00131	CcSEcCtD
Morphine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00104	0.0013	CcSEcCtD
Morphine—Asthenia—Fludarabine—lymphatic system cancer	0.00103	0.0013	CcSEcCtD
Morphine—Rash—Teniposide—lymphatic system cancer	0.00103	0.0013	CcSEcCtD
Morphine—Dermatitis—Teniposide—lymphatic system cancer	0.00103	0.0013	CcSEcCtD
Morphine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00103	0.0013	CcSEcCtD
Morphine—Headache—Teniposide—lymphatic system cancer	0.00103	0.00129	CcSEcCtD
Morphine—Pruritus—Fludarabine—lymphatic system cancer	0.00102	0.00128	CcSEcCtD
Morphine—Back pain—Mitoxantrone—lymphatic system cancer	0.00102	0.00128	CcSEcCtD
Morphine—Leukopenia—Carmustine—lymphatic system cancer	0.00101	0.00127	CcSEcCtD
Morphine—Anorexia—Bleomycin—lymphatic system cancer	0.00101	0.00127	CcSEcCtD
Morphine—Anaemia—Vincristine—lymphatic system cancer	0.000998	0.00126	CcSEcCtD
Morphine—Agitation—Vincristine—lymphatic system cancer	0.000992	0.00125	CcSEcCtD
Morphine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000991	0.00125	CcSEcCtD
Morphine—Polyuria—Methotrexate—lymphatic system cancer	0.000991	0.00125	CcSEcCtD
Morphine—Hypotension—Bleomycin—lymphatic system cancer	0.000988	0.00124	CcSEcCtD
Morphine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000987	0.00124	CcSEcCtD
Morphine—Convulsion—Carmustine—lymphatic system cancer	0.00098	0.00123	CcSEcCtD
Morphine—Hypertension—Carmustine—lymphatic system cancer	0.000977	0.00123	CcSEcCtD
Morphine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000976	0.00123	CcSEcCtD
Morphine—Nausea—Teniposide—lymphatic system cancer	0.000975	0.00123	CcSEcCtD
Morphine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000972	0.00122	CcSEcCtD
Morphine—Vertigo—Vincristine—lymphatic system cancer	0.00097	0.00122	CcSEcCtD
Morphine—Leukopenia—Vincristine—lymphatic system cancer	0.000967	0.00122	CcSEcCtD
Morphine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000964	0.00121	CcSEcCtD
Morphine—Chest pain—Carmustine—lymphatic system cancer	0.000963	0.00121	CcSEcCtD
Morphine—Anxiety—Carmustine—lymphatic system cancer	0.00096	0.00121	CcSEcCtD
Morphine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00095	0.00119	CcSEcCtD
Morphine—Malaise—Mitoxantrone—lymphatic system cancer	0.000948	0.00119	CcSEcCtD
Morphine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000943	0.00119	CcSEcCtD
Morphine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000941	0.00118	CcSEcCtD
Morphine—Convulsion—Vincristine—lymphatic system cancer	0.000936	0.00118	CcSEcCtD
Morphine—Hypertension—Vincristine—lymphatic system cancer	0.000932	0.00117	CcSEcCtD
Morphine—Confusional state—Carmustine—lymphatic system cancer	0.000931	0.00117	CcSEcCtD
Morphine—Oedema—Carmustine—lymphatic system cancer	0.000923	0.00116	CcSEcCtD
Morphine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000919	0.00116	CcSEcCtD
Morphine—Visual disturbance—Methotrexate—lymphatic system cancer	0.000918	0.00115	CcSEcCtD
Morphine—Cough—Mitoxantrone—lymphatic system cancer	0.000918	0.00115	CcSEcCtD
Morphine—Infection—Carmustine—lymphatic system cancer	0.000917	0.00115	CcSEcCtD
Morphine—Vomiting—Fludarabine—lymphatic system cancer	0.000917	0.00115	CcSEcCtD
Morphine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000911	0.00115	CcSEcCtD
Morphine—Rash—Fludarabine—lymphatic system cancer	0.000909	0.00114	CcSEcCtD
Morphine—Dermatitis—Fludarabine—lymphatic system cancer	0.000909	0.00114	CcSEcCtD
Morphine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000908	0.00114	CcSEcCtD
Morphine—Pain—Bleomycin—lymphatic system cancer	0.000904	0.00114	CcSEcCtD
Morphine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000904	0.00114	CcSEcCtD
Morphine—Headache—Fludarabine—lymphatic system cancer	0.000904	0.00114	CcSEcCtD
Morphine—Tachycardia—Carmustine—lymphatic system cancer	0.000901	0.00113	CcSEcCtD
Morphine—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000899	0.00113	CcSEcCtD
Morphine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000895	0.00113	CcSEcCtD
Morphine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000895	0.00113	CcSEcCtD
Morphine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000892	0.00112	CcSEcCtD
Morphine—Lethargy—Methotrexate—lymphatic system cancer	0.000888	0.00112	CcSEcCtD
Morphine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000885	0.00111	CcSEcCtD
Morphine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000881	0.00111	CcSEcCtD
Morphine—Oedema—Vincristine—lymphatic system cancer	0.000881	0.00111	CcSEcCtD
Morphine—Anorexia—Carmustine—lymphatic system cancer	0.00088	0.00111	CcSEcCtD
Morphine—Infection—Vincristine—lymphatic system cancer	0.000876	0.0011	CcSEcCtD
Morphine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000872	0.0011	CcSEcCtD
Morphine—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00087	0.00109	CcSEcCtD
Morphine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000865	0.00109	CcSEcCtD
Morphine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000864	0.00109	CcSEcCtD
Morphine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000863	0.00109	CcSEcCtD
Morphine—Hypotension—Carmustine—lymphatic system cancer	0.000863	0.00108	CcSEcCtD
Morphine—Oedema—Mitoxantrone—lymphatic system cancer	0.000858	0.00108	CcSEcCtD
Morphine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000858	0.00108	CcSEcCtD
Morphine—Nausea—Fludarabine—lymphatic system cancer	0.000857	0.00108	CcSEcCtD
Morphine—Infection—Mitoxantrone—lymphatic system cancer	0.000853	0.00107	CcSEcCtD
Morphine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000852	0.00107	CcSEcCtD
Morphine—Shock—Mitoxantrone—lymphatic system cancer	0.000844	0.00106	CcSEcCtD
Morphine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000841	0.00106	CcSEcCtD
Morphine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00084	0.00106	CcSEcCtD
Morphine—Urticaria—Bleomycin—lymphatic system cancer	0.00084	0.00106	CcSEcCtD
Morphine—Anorexia—Vincristine—lymphatic system cancer	0.00084	0.00106	CcSEcCtD
Morphine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000838	0.00105	CcSEcCtD
Morphine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000836	0.00105	CcSEcCtD
Morphine—Insomnia—Carmustine—lymphatic system cancer	0.000835	0.00105	CcSEcCtD
Morphine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000834	0.00105	CcSEcCtD
Morphine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00083	0.00104	CcSEcCtD
Morphine—Paraesthesia—Carmustine—lymphatic system cancer	0.000829	0.00104	CcSEcCtD
Morphine—Mood swings—Methotrexate—lymphatic system cancer	0.000824	0.00104	CcSEcCtD
Morphine—Hypotension—Vincristine—lymphatic system cancer	0.000823	0.00104	CcSEcCtD
Morphine—Dyspnoea—Carmustine—lymphatic system cancer	0.000823	0.00104	CcSEcCtD
Morphine—Somnolence—Carmustine—lymphatic system cancer	0.000821	0.00103	CcSEcCtD
Morphine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000818	0.00103	CcSEcCtD
Morphine—Ataxia—Methotrexate—lymphatic system cancer	0.000818	0.00103	CcSEcCtD
Morphine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000803	0.00101	CcSEcCtD
Morphine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000803	0.00101	CcSEcCtD
Morphine—Decreased appetite—Carmustine—lymphatic system cancer	0.000803	0.00101	CcSEcCtD
Morphine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000802	0.00101	CcSEcCtD
Morphine—Insomnia—Vincristine—lymphatic system cancer	0.000797	0.001	CcSEcCtD
Morphine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000797	0.001	CcSEcCtD
Morphine—Paraesthesia—Vincristine—lymphatic system cancer	0.000791	0.000995	CcSEcCtD
Morphine—Constipation—Carmustine—lymphatic system cancer	0.000789	0.000993	CcSEcCtD
Morphine—Pain—Carmustine—lymphatic system cancer	0.000789	0.000993	CcSEcCtD
Morphine—Breast disorder—Methotrexate—lymphatic system cancer	0.000786	0.000989	CcSEcCtD
Morphine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000782	0.000983	CcSEcCtD
Morphine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000779	0.00098	CcSEcCtD
Morphine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000771	0.000969	CcSEcCtD
Morphine—Decreased appetite—Vincristine—lymphatic system cancer	0.000766	0.000964	CcSEcCtD
Morphine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000765	0.000962	CcSEcCtD
Morphine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000763	0.00096	CcSEcCtD
Morphine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000761	0.000957	CcSEcCtD
Morphine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000761	0.000957	CcSEcCtD
Morphine—Fatigue—Vincristine—lymphatic system cancer	0.00076	0.000956	CcSEcCtD
Morphine—Asthenia—Bleomycin—lymphatic system cancer	0.000759	0.000954	CcSEcCtD
Morphine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000755	0.00095	CcSEcCtD
Morphine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000755	0.000949	CcSEcCtD
Morphine—Constipation—Vincristine—lymphatic system cancer	0.000754	0.000948	CcSEcCtD
Morphine—Pain—Vincristine—lymphatic system cancer	0.000754	0.000948	CcSEcCtD
Morphine—Pruritus—Bleomycin—lymphatic system cancer	0.000748	0.000941	CcSEcCtD
Morphine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000746	0.000938	CcSEcCtD
Morphine—Eosinophilia—Methotrexate—lymphatic system cancer	0.000745	0.000936	CcSEcCtD
Morphine—Fatigue—Mitoxantrone—lymphatic system cancer	0.00074	0.000931	CcSEcCtD
Morphine—Pain—Mitoxantrone—lymphatic system cancer	0.000734	0.000923	CcSEcCtD
Morphine—Constipation—Mitoxantrone—lymphatic system cancer	0.000734	0.000923	CcSEcCtD
Morphine—Abdominal pain—Carmustine—lymphatic system cancer	0.00073	0.000918	CcSEcCtD
Morphine—Body temperature increased—Carmustine—lymphatic system cancer	0.00073	0.000918	CcSEcCtD
Morphine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000721	0.000906	CcSEcCtD
Morphine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000707	0.00089	CcSEcCtD
Morphine—Dysuria—Methotrexate—lymphatic system cancer	0.000703	0.000884	CcSEcCtD
Morphine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000702	0.000883	CcSEcCtD
Morphine—Body temperature increased—Vincristine—lymphatic system cancer	0.000697	0.000876	CcSEcCtD
Morphine—Abdominal pain—Vincristine—lymphatic system cancer	0.000697	0.000876	CcSEcCtD
Morphine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000693	0.000871	CcSEcCtD
Morphine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000682	0.000858	CcSEcCtD
Morphine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00068	0.000855	CcSEcCtD
Morphine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000678	0.000853	CcSEcCtD
Morphine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000678	0.000853	CcSEcCtD
Morphine—Vomiting—Bleomycin—lymphatic system cancer	0.000672	0.000846	CcSEcCtD
Morphine—Drowsiness—Methotrexate—lymphatic system cancer	0.00067	0.000843	CcSEcCtD
Morphine—Rash—Bleomycin—lymphatic system cancer	0.000667	0.000839	CcSEcCtD
Morphine—Dermatitis—Bleomycin—lymphatic system cancer	0.000666	0.000838	CcSEcCtD
Morphine—Asthenia—Carmustine—lymphatic system cancer	0.000662	0.000833	CcSEcCtD
Morphine—Renal failure—Methotrexate—lymphatic system cancer	0.000659	0.000829	CcSEcCtD
Morphine—Stomatitis—Methotrexate—lymphatic system cancer	0.000654	0.000822	CcSEcCtD
Morphine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000652	0.00082	CcSEcCtD
Morphine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000649	0.000817	CcSEcCtD
Morphine—Sweating—Methotrexate—lymphatic system cancer	0.000643	0.000808	CcSEcCtD
Morphine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000634	0.000798	CcSEcCtD
Morphine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000632	0.000795	CcSEcCtD
Morphine—Asthenia—Vincristine—lymphatic system cancer	0.000632	0.000795	CcSEcCtD
Morphine—Diarrhoea—Carmustine—lymphatic system cancer	0.000632	0.000794	CcSEcCtD
Morphine—Nausea—Bleomycin—lymphatic system cancer	0.000628	0.00079	CcSEcCtD
Morphine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000616	0.000774	CcSEcCtD
Morphine—Dizziness—Carmustine—lymphatic system cancer	0.00061	0.000768	CcSEcCtD
Morphine—Diarrhoea—Vincristine—lymphatic system cancer	0.000603	0.000758	CcSEcCtD
Morphine—Hepatitis—Methotrexate—lymphatic system cancer	0.000602	0.000757	CcSEcCtD
Morphine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000594	0.000748	CcSEcCtD
Morphine—Urethral disorder—Methotrexate—lymphatic system cancer	0.00059	0.000742	CcSEcCtD
Morphine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000587	0.000739	CcSEcCtD
Morphine—Vomiting—Carmustine—lymphatic system cancer	0.000587	0.000738	CcSEcCtD
Morphine—Dizziness—Vincristine—lymphatic system cancer	0.000583	0.000733	CcSEcCtD
Morphine—Rash—Carmustine—lymphatic system cancer	0.000582	0.000732	CcSEcCtD
Morphine—Dermatitis—Carmustine—lymphatic system cancer	0.000582	0.000731	CcSEcCtD
Morphine—Visual impairment—Methotrexate—lymphatic system cancer	0.00058	0.00073	CcSEcCtD
Morphine—Headache—Carmustine—lymphatic system cancer	0.000578	0.000727	CcSEcCtD
Morphine—Eye disorder—Methotrexate—lymphatic system cancer	0.000562	0.000707	CcSEcCtD
Morphine—Vomiting—Vincristine—lymphatic system cancer	0.00056	0.000705	CcSEcCtD
Morphine—Rash—Vincristine—lymphatic system cancer	0.000556	0.000699	CcSEcCtD
Morphine—Dermatitis—Vincristine—lymphatic system cancer	0.000555	0.000698	CcSEcCtD
Morphine—Headache—Vincristine—lymphatic system cancer	0.000552	0.000694	CcSEcCtD
Morphine—Nausea—Carmustine—lymphatic system cancer	0.000548	0.00069	CcSEcCtD
Morphine—Angiopathy—Methotrexate—lymphatic system cancer	0.000546	0.000687	CcSEcCtD
Morphine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000546	0.000686	CcSEcCtD
Morphine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000542	0.000682	CcSEcCtD
Morphine—Rash—Mitoxantrone—lymphatic system cancer	0.000541	0.000681	CcSEcCtD
Morphine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000541	0.00068	CcSEcCtD
Morphine—Chills—Methotrexate—lymphatic system cancer	0.00054	0.000679	CcSEcCtD
Morphine—Headache—Mitoxantrone—lymphatic system cancer	0.000538	0.000676	CcSEcCtD
Morphine—Mental disorder—Methotrexate—lymphatic system cancer	0.000527	0.000663	CcSEcCtD
Morphine—Malnutrition—Methotrexate—lymphatic system cancer	0.000524	0.000659	CcSEcCtD
Morphine—Erythema—Methotrexate—lymphatic system cancer	0.000524	0.000659	CcSEcCtD
Morphine—Nausea—Vincristine—lymphatic system cancer	0.000523	0.000658	CcSEcCtD
Morphine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000513	0.000645	CcSEcCtD
Morphine—Nausea—Mitoxantrone—lymphatic system cancer	0.00051	0.000641	CcSEcCtD
Morphine—Back pain—Methotrexate—lymphatic system cancer	0.000507	0.000637	CcSEcCtD
Morphine—Vision blurred—Methotrexate—lymphatic system cancer	0.000494	0.000621	CcSEcCtD
Morphine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000486	0.000611	CcSEcCtD
Morphine—Anaemia—Methotrexate—lymphatic system cancer	0.000484	0.000609	CcSEcCtD
Morphine—Malaise—Methotrexate—lymphatic system cancer	0.000472	0.000594	CcSEcCtD
Morphine—Vertigo—Methotrexate—lymphatic system cancer	0.000471	0.000592	CcSEcCtD
Morphine—Leukopenia—Methotrexate—lymphatic system cancer	0.000469	0.00059	CcSEcCtD
Morphine—Cough—Methotrexate—lymphatic system cancer	0.000457	0.000575	CcSEcCtD
Morphine—Convulsion—Methotrexate—lymphatic system cancer	0.000454	0.000571	CcSEcCtD
Morphine—Arthralgia—Methotrexate—lymphatic system cancer	0.000446	0.000561	CcSEcCtD
Morphine—Chest pain—Methotrexate—lymphatic system cancer	0.000446	0.000561	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000443	0.000557	CcSEcCtD
Morphine—Discomfort—Methotrexate—lymphatic system cancer	0.000441	0.000554	CcSEcCtD
Morphine—Confusional state—Methotrexate—lymphatic system cancer	0.000431	0.000542	CcSEcCtD
Morphine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000428	0.000538	CcSEcCtD
Morphine—Infection—Methotrexate—lymphatic system cancer	0.000425	0.000534	CcSEcCtD
Morphine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000419	0.000527	CcSEcCtD
Morphine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000419	0.000527	CcSEcCtD
Morphine—Skin disorder—Methotrexate—lymphatic system cancer	0.000415	0.000522	CcSEcCtD
Morphine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000413	0.00052	CcSEcCtD
Morphine—Anorexia—Methotrexate—lymphatic system cancer	0.000408	0.000513	CcSEcCtD
Morphine—Hypotension—Methotrexate—lymphatic system cancer	0.0004	0.000503	CcSEcCtD
Morphine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00039	0.00049	CcSEcCtD
Morphine—Insomnia—Methotrexate—lymphatic system cancer	0.000387	0.000486	CcSEcCtD
Morphine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000384	0.000483	CcSEcCtD
Morphine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000381	0.000479	CcSEcCtD
Morphine—Somnolence—Methotrexate—lymphatic system cancer	0.00038	0.000478	CcSEcCtD
Morphine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000376	0.000473	CcSEcCtD
Morphine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000372	0.000468	CcSEcCtD
Morphine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000369	0.000464	CcSEcCtD
Morphine—Fatigue—Methotrexate—lymphatic system cancer	0.000369	0.000464	CcSEcCtD
Morphine—Pain—Methotrexate—lymphatic system cancer	0.000366	0.00046	CcSEcCtD
Morphine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000352	0.000443	CcSEcCtD
Morphine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00035	0.00044	CcSEcCtD
Morphine—Urticaria—Methotrexate—lymphatic system cancer	0.00034	0.000427	CcSEcCtD
Morphine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000338	0.000425	CcSEcCtD
Morphine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000338	0.000425	CcSEcCtD
Morphine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000315	0.000396	CcSEcCtD
Morphine—Asthenia—Methotrexate—lymphatic system cancer	0.000307	0.000386	CcSEcCtD
Morphine—Pruritus—Methotrexate—lymphatic system cancer	0.000303	0.000381	CcSEcCtD
Morphine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000293	0.000368	CcSEcCtD
Morphine—Dizziness—Methotrexate—lymphatic system cancer	0.000283	0.000356	CcSEcCtD
Morphine—Vomiting—Methotrexate—lymphatic system cancer	0.000272	0.000342	CcSEcCtD
Morphine—Rash—Methotrexate—lymphatic system cancer	0.00027	0.000339	CcSEcCtD
Morphine—Dermatitis—Methotrexate—lymphatic system cancer	0.000269	0.000339	CcSEcCtD
Morphine—Headache—Methotrexate—lymphatic system cancer	0.000268	0.000337	CcSEcCtD
Morphine—Nausea—Methotrexate—lymphatic system cancer	0.000254	0.000319	CcSEcCtD
